[Instillation therapies for urothelial carcinoma of the upper urinary tract].
Instillationstherapien beim Urothelkarzinom des oberen Harntraktes.
Administration, Intravesical
Aged
Carcinoma in Situ
Carcinoma, Transitional Cell
/ pathology
Cystectomy
Female
Humans
Instillation, Drug
Kidney
/ pathology
Male
Neoplasm Recurrence, Local
/ pathology
Retrospective Studies
Ureter
Ureteral Neoplasms
/ pathology
Urinary Bladder
/ pathology
Urinary Tract
Urologic Neoplasms
/ surgery
Bacillus Calmette-Guérin
Carcinoma in situ
Mitomycin C
Nephroureterectomy
Vesico-ureteral reflux
Journal
Der Urologe. Ausg. A
ISSN: 1433-0563
Titre abrégé: Urologe A
Pays: Germany
ID NLM: 1304110
Informations de publication
Date de publication:
Jan 2019
Jan 2019
Historique:
pubmed:
17
1
2019
medline:
25
7
2019
entrez:
17
1
2019
Statut:
ppublish
Résumé
Traditionally, urothelial carcinoma of the upper urinary tract was a clear indication for radical nephroureterectomy with bladder cuff excision. It has been shown that in well-selected patients and depending on tumor stage, a kidney-sparing approach can be pursued with good oncological outcome and equivalent to the radical approach. The prevention of local and bladder recurrences is an important factor. Instillation therapies with bacillus Calmette-Guérin and/or mitomycin C have been successfully used to this end. Due to the low incidence of upper tract urothelial cancer and due to the usually retrospective nature of existing literature, however, data is limited. In this article, we provide a review of the indication, technical execution and results of instillation therapies of the upper urinary tract.
Identifiants
pubmed: 30649582
doi: 10.1007/s00120-018-0830-0
pii: 10.1007/s00120-018-0830-0
doi:
Types de publication
Journal Article
Review
Langues
ger
Pagination
25-29Références
BJU Int. 2013 Aug;112(4):453-61
pubmed: 23464979
BJU Int. 2012 Dec;110(11):1608-17
pubmed: 22564677
Urol Ann. 2013 Jul;5(3):184-9
pubmed: 24049383
J Urol. 2010 Jun;183(6):2148-53
pubmed: 20399468
Urology. 1999 Aug;54(2):240-6
pubmed: 10443718
Eur Urol. 2015 Dec;68(6):970-7
pubmed: 26278805
Lancet Oncol. 2006 Sep;7(9):735-40
pubmed: 16945768
Urology. 2006 Jun;67(6):1181-7
pubmed: 16765178
Urology. 2008 Apr;71(4):713-7
pubmed: 18267338
J Urol. 1995 Nov;154(5):1629-35
pubmed: 7563308
J Urol. 2000 Oct;164(4):1173-6
pubmed: 10992360
Urology. 2002 Jan;59(1):53-7
pubmed: 11796281
Med Oncol. 2018 Feb 26;35(4):41
pubmed: 29480348
Urology. 2013 Dec;82(6):1451.e1-6
pubmed: 24139525
Cancer. 2003 Jul 1;98(1):55-60
pubmed: 12833455
BMC Med Genomics. 2010 Dec 15;3:58
pubmed: 21159190
J Urol. 1985 Sep;134(3):531-2
pubmed: 4032555
Case Rep Urol. 2013;2013:819470
pubmed: 24288648
J Endourol. 2011 Mar;25(3):377-84
pubmed: 21401392
J Urol. 1996 Aug;156(2 Pt 1):377-85
pubmed: 8683683
BJU Int. 2012 Sep;110(5):614-28
pubmed: 22471401
J Urol. 1976 Aug;116(2):180-3
pubmed: 820877
J Urol. 2002 Oct;168(4 Pt 1):1381-5
pubmed: 12352398
J Urol. 2014 Apr;191(4):926-31
pubmed: 24060642
Eur J Surg Oncol. 2014 Dec;40(12):1629-34
pubmed: 25108813
Eur Urol. 2011 Nov;60(5):955-60
pubmed: 21807456
J Urol. 2010 Jul;184(1):74-80
pubmed: 20546806
Nat Rev Urol. 2018 Oct;15(10):615-625
pubmed: 29991725
Urol Oncol. 2014 Jan;32(1):45.e23-30
pubmed: 24055426
Urol Int. 2013;91(3):291-6
pubmed: 23948770